Surbiton-Biotech firm AorTech Biomaterials, developer of the biomedical silicone-polyurethane material Elast-Eon, has gained grants from various Australian government agencies. A total of some $1 million AUD (about $745 000) will be awarded for the first half of 2006 to support AorTech's investment in R&D activities and infrastructure. AorTech added that it intends to move the headquarters of its Australian operations to an expanded facility in Melbourne.In a statement, the Surbiton-headquartered Aortech International plc operation pointed out that the Australian biotech industry is "a vibrant and growing sector … underpinned by world-leading research and clinical facilities, and strong government commitment." "
